To access the full text documents, please follow this link: http://hdl.handle.net/2445/123933
dc.contributor.author | Molina Molina, María |
---|---|
dc.contributor.author | Machahua-Huamani, C. |
dc.contributor.author | Vicens-Zygmunt, Vanesa |
dc.contributor.author | Llatjós, Roger |
dc.contributor.author | Escobar, I. |
dc.contributor.author | Sala-Llinas, E. |
dc.contributor.author | Luburich-Hernaiz, P. |
dc.contributor.author | Dorca i Sargatal, Jordi |
dc.contributor.author | Montes-Worboys, A. |
dc.date | 2018-07-25T10:40:59Z |
dc.date | 2018-07-25T10:40:59Z |
dc.date | 2018-04-27 |
dc.date | 2018-07-24T11:42:58Z |
dc.identifier.uri | http://hdl.handle.net/2445/123933 |
dc.format | 13 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Biomed Central Ltd |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1186/s12890-018-0626-4 |
dc.relation | Bmc Pulmonary Medicine, 2018, Vol. 18:63 |
dc.relation | https://doi.org/10.1186/s12890-018-0626-4 |
dc.rights | cc-by (c) Molina-Molina, María et al., 2018 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es/ |
dc.subject | Fibrosi pulmonar |
dc.subject | Matriu extracel·lular |
dc.subject | Terapèutica |
dc.subject | Therapeutics |
dc.subject | Pulmonary fibrosis |
dc.subject | Extracellular matrix |
dc.title | Anti-fibrotic Effects Of Pirfenidone And Rapamycin In Primary Ipf Fibroblasts And Human Alveolar Epithelial Cells |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |